By treating PDLIM1-sh1, PDLIM-sh2, and scramble control U87 cells with TMZ, we found that PDLIM1 knockdown rendered GBM cells more sensitive to TMZ treatment (Fig. 7C). This evidence concerns the gene PDLIM1 and glioblastoma.